Browse by author
Lookup NU author(s): Professor Richard McQuade, Professor Allan Young
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background. The hypercortisolaemia and dysfunction of the hypothalamic pituitary - adrenal (HPA) axis associated with mood disorders have been attributed to a breakdown in the glucocorticoid-receptor-mediated negative feedback mechanism regulating HPA activity. Reinstating normal feedback may be therapeutic in mood disorders. Aims. To review the evidence for the involvement of the glucocorticoid receptor in the pathogenesis and treatment of mood disorders. Method. Medline and hand searches were carried out, selecting literature relevant to psychiatrists and psychopharmacologists. Results. A dysfunction in glucocorticoid receptors is integral to the HPA abnormalities of mood disorders. Antidepressant and mood-stabilising drugs can up-regulate glucocorticoid receptors, restoring glucocorticoid function. Preliminary clinical studies targeting the glucocorticoid receptor are encouraging. Conclusions. Drugs designed specifically to up-regulate glucocorticoid receptors may be integral to future strategies in treating mood disorders. Declaration of interest. None.
Author(s): Young AH; McQuade R
Publication type: Review
Publication status: Published
Journal: British Journal of Psychiatry
Year: 2000
Volume: 177
Pages: 390-395
Print publication date: 01/01/2000
ISSN (print): 0007-1250
ISSN (electronic): 1472-1465
URL: http://dx.doi.org/10.1192/bjp.177.5.390
DOI: 10.1192/bjp.177.5.390
PubMed id: 11059990
